MedPath

Evaluation of Safety of Filler Injection in Subcutaneous Tissues

Not Applicable
Not yet recruiting
Conditions
Volume Deficiency
Interventions
Device: Adipearl
Registration Number
NCT06322043
Lead Sponsor
Volumina Medical S.A.
Brief Summary

Adipearl is an injectable filler intended to be injected subcutaneously.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Subject having given freely and expressly informed consent;
  • Subject deemed by the Investigator to be medically fit for injection of the product;
  • Female or male subjects aged 22 to 65 years (inclusive);
Exclusion Criteria
  • Pregnant or nursing woman or planning a pregnancy during the study.
  • Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
  • Subject participating to another research study.
  • Subject with the presence of any condition, which in the opinion of the Principal Investigator, that makes her/him unable to complete the study per protocol.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Volume correction with Investigational DeviceAdipearlSubjects will be injected subcutaneously with the Investigational Device to correct volume deficiencies.
Primary Outcome Measures
NameTimeMethod
Safety of Investigational Medical Device6-Months

Collection of Injection Site Reactions and Adverse Events during the study.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Summit Clinic

🇨🇭

Crans-Montana, Switzerland

© Copyright 2025. All Rights Reserved by MedPath